Piper Sandler Maintains Overweight on Innovex International, Raises Price Target to $27
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Derek Podhaizer maintains Innovex International (NYSE:INVX) with a Overweight and raises the price target from $20 to $27.
Piper Sandler analyst Derek Podhaizer maintains Innovex International (NYSE:INVX) with a Overweight and raises the price target from $20 to $27.